Información:
Error:
ID
28248
Descripción
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Informed consent (Screening) Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Palabras clave
Versiones (4)
- 25/11/17 25/11/17 -
- 25/11/17 25/11/17 -
- 30/11/17 30/11/17 -
- 31/12/17 31/12/17 -
Titular de derechos de autor
Prof. Dr. med. Georg Heß
Subido en
31 de diciembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Similar models
Screening Informed consent GOAL Trial B-cell Lymphoma NCT02499003
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Site Number
Item
Site No
text
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
Screening number
Item
Screening no
text
C1710477 (UMLS CUI [1])
Informed consent availability
Item
Signed and dated informed consent of the patient is available before start of any trial specific procedures
boolean
C0021430 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,2])
Date of informed consent
Item
Date of informed consent
date
C2985782 (UMLS CUI [1])
Study subject participation status
Item
Participation in contributing scientific investigations
boolean
C2348568 (UMLS CUI [1])